Prognostic impact of COX-2 in non-small cell lung cancer: A comprehensive compartment-specific evaluation of tumor and stromal cell expression
Johanna Sofia Margareta Mattsson(Uppsala University), Miklós Gulyás(Uppsala University), Millaray Marincevic(Uppsala University), Gisela Helenius(Skåne University Hospital), Karin Jirström(Lund University), Marianna Grinberg(TU Dortmund University), Jan G. Hengstler(TU Dortmund University), Bengt Bergman(Sahlgrenska University Hospital), Patrick Micke(Uppsala University Hospital), Karolina Edlund(Uppsala University Hospital), Mats G. Karlsson(Uppsala University Hospital), Jörg Rahnenführer(TU Dortmund University), Christina Karlsson(Uppsala University Hospital), Johan Botling(Uppsala University Hospital), Fredrik Pontén(Uppsala University)
Cited by 29
Related Papers
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
|JNCI Journal of the National Cancer Institute|1993|15.9k
The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials
|European Journal of Cancer|1994|878
<i>In vivo</i> biocompatibility of bacterial cellulose
|Journal of Biomedical Materials Research Part A|2005|688
Mechanical properties of bacterial cellulose and interactions with smooth muscle cells
|Biomaterials|2005|565